Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Hu

Showing results (71-80 of 327) with videos related to

Pageof 33
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[A prospective study on the association between dyslipidemia and hypertension]Zhi-Rong Guo, Xiao-Shu Hu, Ming Wu, et al.
Journal of Biomedicine & Biotechnology|April 17, 2012
Reduced striatal dopamine transporters in people with internet addiction disorderHaifeng Hou, Shaowe Jia, Shu Hu, et al.
Ultrasonics Sonochemistry|April 22, 2021
Optimization and mechanism exploration for Escherichia coli transformed with plasmid pUC19 by the combination with ultrasound treatment and chemical methodYonggang Wang, Shangchen Sun, Linmiao Yu, et al.
Journal of Cellular Biochemistry|March 12, 2019
miR-193b-5p regulates chondrocytes metabolism by directly targeting histone deacetylase 7 in interleukin-1β-induced osteoarthritisChengyun Zhang, Zhiqi Zhang, Zongkun Chang, et al.
Minerva Cardioangiologica|October 23, 2019
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®Shu Hu, Morio Hosoi, Gianni Belcaro, et al.
Huan Jing Ke Xue= Huanjing Kexue|March 2, 2010
[Removal of arsenate from drinking water by activated carbon supported nano zero-valent iron]Hui-jie Zhu, Yong-feng Jia, Shu-hu Yao, et al.
ACS Nano|November 16, 2024
Shell-Isolated Nanoparticle-Enhanced Raman Spectroscopy: Toward High Sensitivity and Broad ApplicabilityYue-Zhou Zhu, Ru-Yu Zhou, Shu Hu, et al.
Minerva Cardioangiologica|October 18, 2018
Efficacy of Pycnogenol® supplementation in remission phases of Sjögren syndromeRoberta Luzzi, Gianni Belcaro, Shu Hu, et al.
Lipids in Health and Disease|July 9, 2014
The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in ChinaChen Chen, Yan Xu, Zhi-rong Guo, et al.
Lipids in Health and Disease|January 28, 2014
PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han populationShu-Jun Gu, Zhi-Rong Guo, Zheng-Yuan Zhou, et al.
Pageof 33

Showing results (71-80 of 327) with videos related to

Sort By:
Pageof 33
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 5, 2009
[A prospective study on the association between dyslipidemia and hypertension]Zhi-Rong Guo, Xiao-Shu Hu, Ming Wu, et al.
Journal of Biomedicine & Biotechnology|April 17, 2012
Reduced striatal dopamine transporters in people with internet addiction disorderHaifeng Hou, Shaowe Jia, Shu Hu, et al.
Ultrasonics Sonochemistry|April 22, 2021
Optimization and mechanism exploration for Escherichia coli transformed with plasmid pUC19 by the combination with ultrasound treatment and chemical methodYonggang Wang, Shangchen Sun, Linmiao Yu, et al.
Journal of Cellular Biochemistry|March 12, 2019
miR-193b-5p regulates chondrocytes metabolism by directly targeting histone deacetylase 7 in interleukin-1β-induced osteoarthritisChengyun Zhang, Zhiqi Zhang, Zongkun Chang, et al.
Minerva Cardioangiologica|October 23, 2019
Management of mild, primary Raynaud Syndrome: supplementation with Pycnogenol®Shu Hu, Morio Hosoi, Gianni Belcaro, et al.
Huan Jing Ke Xue= Huanjing Kexue|March 2, 2010
[Removal of arsenate from drinking water by activated carbon supported nano zero-valent iron]Hui-jie Zhu, Yong-feng Jia, Shu-hu Yao, et al.
ACS Nano|November 16, 2024
Shell-Isolated Nanoparticle-Enhanced Raman Spectroscopy: Toward High Sensitivity and Broad ApplicabilityYue-Zhou Zhu, Ru-Yu Zhou, Shu Hu, et al.
Minerva Cardioangiologica|October 18, 2018
Efficacy of Pycnogenol® supplementation in remission phases of Sjögren syndromeRoberta Luzzi, Gianni Belcaro, Shu Hu, et al.
Lipids in Health and Disease|July 9, 2014
The application of visceral adiposity index in identifying type 2 diabetes risks based on a prospective cohort in ChinaChen Chen, Yan Xu, Zhi-rong Guo, et al.
Lipids in Health and Disease|January 28, 2014
PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han populationShu-Jun Gu, Zhi-Rong Guo, Zheng-Yuan Zhou, et al.
Pageof 33